Researchers assess use of tick molecule for COVID-19

UK-based biotech ILC Therapeutics is working with the University of Oxford to investigate whether the use of evasins – molecules derived from ticks – could offer a new treatment option for patients with COVID-19 with significant lung damage.

Source:

PharmaTimes